Skip to main content

Alumis Inc (ALMS)

Red

Health Care · As of 17 July 2026

Price chart — 52 weeks

ALMS · 28.66 (last weekly close) SMA 10w SMA 40w
51015202530AugSepOctNovDec2026FebMarAprMayJunJul50.0MWeek of Jul 21, 2025 · O 3.40 · H 4.16 · L 3.25 · C 3.88 · Vol 3.8MWeek of Jul 28, 2025 · O 3.87 · H 4.28 · L 3.75 · C 4.13 · Vol 4.5MWeek of Aug 4, 2025 · O 4.14 · H 4.40 · L 4.04 · C 4.30 · Vol 2.8MWeek of Aug 11, 2025 · O 4.25 · H 4.77 · L 4.09 · C 4.75 · Vol 4.1MWeek of Aug 18, 2025 · O 4.74 · H 5.13 · L 4.33 · C 4.84 · Vol 3.5MWeek of Aug 25, 2025 · O 4.85 · H 5.00 · L 4.57 · C 4.64 · Vol 3.1MWeek of Sep 1, 2025 · O 4.64 · H 4.83 · L 4.32 · C 4.51 · Vol 2.3MWeek of Sep 8, 2025 · O 4.50 · H 4.52 · L 4.12 · C 4.37 · Vol 2.0MWeek of Sep 15, 2025 · O 4.36 · H 4.47 · L 4.08 · C 4.17 · Vol 3.6MWeek of Sep 22, 2025 · O 4.16 · H 4.29 · L 3.84 · C 4.05 · Vol 2.4MWeek of Sep 29, 2025 · O 4.05 · H 4.15 · L 3.76 · C 4.02 · Vol 2.2MWeek of Oct 6, 2025 · O 4.07 · H 4.70 · L 3.97 · C 4.44 · Vol 5.3MWeek of Oct 13, 2025 · O 4.50 · H 4.91 · L 4.38 · C 4.49 · Vol 3.2MWeek of Oct 20, 2025 · O 4.52 · H 4.83 · L 4.37 · C 4.51 · Vol 2.1MWeek of Oct 27, 2025 · O 4.51 · H 4.88 · L 4.51 · C 4.75 · Vol 2.1MWeek of Nov 3, 2025 · O 4.71 · H 4.85 · L 4.39 · C 4.72 · Vol 4.1MWeek of Nov 10, 2025 · O 4.75 · H 5.64 · L 4.59 · C 5.52 · Vol 6.3MWeek of Nov 17, 2025 · O 5.52 · H 7.75 · L 5.44 · C 7.30 · Vol 8.3MWeek of Nov 24, 2025 · O 7.49 · H 7.78 · L 6.93 · C 7.67 · Vol 3.8MWeek of Dec 1, 2025 · O 7.48 · H 11.30 · L 7.31 · C 11.12 · Vol 9.2MWeek of Dec 8, 2025 · O 11.00 · H 12.44 · L 10.51 · C 11.49 · Vol 5.9MWeek of Dec 15, 2025 · O 11.56 · H 11.71 · L 10.44 · C 11.29 · Vol 6.5MWeek of Dec 22, 2025 · O 11.17 · H 11.69 · L 10.83 · C 10.97 · Vol 2.7MWeek of Dec 29, 2025 · O 10.88 · H 11.17 · L 8.68 · C 8.96 · Vol 3.4MWeek of Jan 5, 2026 · O 8.90 · H 22.30 · L 7.85 · C 19.56 · Vol 92.3MWeek of Jan 12, 2026 · O 19.55 · H 25.19 · L 19.55 · C 23.86 · Vol 17.0MWeek of Jan 19, 2026 · O 23.32 · H 27.20 · L 23.18 · C 24.52 · Vol 8.8MWeek of Jan 26, 2026 · O 24.30 · H 28.29 · L 23.45 · C 24.51 · Vol 9.5MWeek of Feb 2, 2026 · O 24.46 · H 27.78 · L 24.26 · C 26.19 · Vol 6.0MWeek of Feb 9, 2026 · O 26.39 · H 28.00 · L 24.80 · C 26.54 · Vol 6.1MWeek of Feb 16, 2026 · O 26.10 · H 30.60 · L 25.70 · C 27.97 · Vol 6.1MWeek of Feb 23, 2026 · O 28.35 · H 30.03 · L 27.04 · C 29.69 · Vol 6.7MWeek of Mar 2, 2026 · O 28.97 · H 30.06 · L 26.47 · C 26.90 · Vol 5.5MWeek of Mar 9, 2026 · O 26.90 · H 28.44 · L 24.56 · C 24.81 · Vol 6.7MWeek of Mar 16, 2026 · O 25.40 · H 26.46 · L 24.00 · C 25.06 · Vol 8.9MWeek of Mar 23, 2026 · O 24.81 · H 26.40 · L 22.08 · C 24.80 · Vol 7.6MWeek of Mar 30, 2026 · O 24.00 · H 24.67 · L 19.86 · C 23.37 · Vol 11.4MWeek of Apr 6, 2026 · O 23.28 · H 23.79 · L 21.00 · C 23.05 · Vol 5.9MWeek of Apr 13, 2026 · O 23.01 · H 25.91 · L 22.20 · C 24.99 · Vol 6.4MWeek of Apr 20, 2026 · O 24.77 · H 28.31 · L 24.49 · C 24.93 · Vol 6.9MWeek of Apr 27, 2026 · O 24.20 · H 25.63 · L 22.84 · C 25.18 · Vol 5.1MWeek of May 4, 2026 · O 25.21 · H 26.50 · L 23.44 · C 23.66 · Vol 4.4MWeek of May 11, 2026 · O 23.70 · H 25.39 · L 22.50 · C 22.87 · Vol 3.9MWeek of May 18, 2026 · O 23.06 · H 23.39 · L 20.53 · C 22.02 · Vol 4.8MWeek of May 25, 2026 · O 22.44 · H 22.56 · L 20.99 · C 21.60 · Vol 3.0MWeek of Jun 1, 2026 · O 21.10 · H 21.60 · L 19.04 · C 19.06 · Vol 6.5MWeek of Jun 8, 2026 · O 19.89 · H 24.29 · L 18.36 · C 24.15 · Vol 8.3MWeek of Jun 15, 2026 · O 24.39 · H 24.83 · L 21.98 · C 23.41 · Vol 5.8MWeek of Jun 22, 2026 · O 23.96 · H 26.50 · L 22.96 · C 26.40 · Vol 10.9MWeek of Jun 29, 2026 · O 26.40 · H 28.65 · L 25.48 · C 26.50 · Vol 7.1MWeek of Jul 6, 2026 · O 26.34 · H 31.35 · L 25.95 · C 28.31 · Vol 10.3MWeek of Jul 13, 2026 · O 28.07 · H 28.97 · L 26.15 · C 28.66 · Vol 7.0M28.66
Weekly candles over the last 52 weeks, split-adjusted, with 10- and 40-week moving averages; trading volume along the bottom. As of Jul 13, 2026.

OakBag could not build a reliable fair-value estimate for Alumis Inc (ALMS) — none of its valuation methods cleared the model's safety checks (typically a company running an operating loss, where a discount can't be trusted). At a recent price of $28.66 the traffic light is set so it looks expensive or risky, benchmarked against other Health Care names. This is a model output for research, not a price target or a recommendation.

Fair value vs. price

Current price
$28.66
Estimated fair value
Margin of safety

How the fair value is built

How is this computed?

Knock-out safety checks failed

  • Bankruptcy risk (Altman Z″)
  • Negative equity
  • Excessive leverage
  • Illiquid
  • Penny / micro-cap
  • Stale fundamentals
Piotroski F-score
2 / 9
Altman Z-score
4.08
Beneish M-score
-0.61

Quality & factor profile

Value -1.03
Quality -1.01
Profitability -1.06
Momentum +2.87
Growth +0.00
Low volatility -2.27

See the full analysis

Create a free OakBag account to unlock every valuation method, price history, watchlists and email alerts for ALMS and 1,850+ other stocks.

No credit card · just an email

Frequently asked questions

Is Alumis (ALMS) undervalued?

OakBag could not build a reliable fair-value estimate for Alumis Inc — none of its valuation methods cleared the model's safety checks, which usually happens for a company running an operating loss. At a recent price of $28.66 the model looks expensive or risky. This is a model output, not investment advice.

What is margin of safety?

Margin of safety is how far below the estimated fair value the price sits: (fair value − price) ÷ fair value. It cannot be shown here because no reliable fair-value estimate could be built for this stock.

Does a green verdict mean I should buy ALMS?

No. OakBag is an educational and research tool, not investment advice. The traffic light is an automated model output based on third-party data that may be delayed or inaccurate. Always do your own research.

Other Health Care stocks

An educational and research tool — not investment advice. OakBag is an educational and research tool, not investment advice. Scores and rankings are automated model outputs based on third-party data and may be inaccurate or delayed. Nothing here is a recommendation to buy or sell any security. Investing involves risk, including possible loss of principal.